These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 25661982)

  • 1. Socio-economic burden of rare diseases: A systematic review of cost of illness evidence.
    Angelis A; Tordrup D; Kanavos P
    Health Policy; 2015 Jul; 119(7):964-79. PubMed ID: 25661982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study.
    Linertová R; Serrano-Aguilar P; Posada-de-la-Paz M; Hens-Pérez M; Kanavos P; Taruscio D; Schieppati A; Stefanov R; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G; Worbes-Cerezo M; Sefton M; López-Bastida J;
    Health Policy; 2012 Nov; 108(1):19-26. PubMed ID: 22947412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-of-Illness in Rare Diseases.
    Linertová R; García-Pérez L; Gorostiza I
    Adv Exp Med Biol; 2017; 1031():283-297. PubMed ID: 29214579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.
    Angelis A; Mellerio JE; Kanavos P
    Orphanet J Rare Dis; 2022 Sep; 17(1):346. PubMed ID: 36068590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases.
    Schlander M; Dintsios CM; Gandjour A
    Value Health; 2018 May; 21(5):525-531. PubMed ID: 29753348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
    BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
    Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden and health-related quality of life associated with Prader-Willi syndrome in France.
    Chevreul K; Berg Brigham K; Clément MC; Poitou C; Tauber M;
    J Intellect Disabil Res; 2016 Sep; 60(9):879-90. PubMed ID: 27174598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
    BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
    Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilia A: health and economic burden of a rare disease in Portugal.
    Café A; Carvalho M; Crato M; Faria M; Kjollerstrom P; Oliveira C; Pinto PR; Salvado R; Dos Santos AA; Silva C
    Orphanet J Rare Dis; 2019 Sep; 14(1):211. PubMed ID: 31484564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
    Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany.
    Schreiber-Katz O; Klug C; Thiele S; Schorling E; Zowe J; Reilich P; Nagels KH; Walter MC
    Orphanet J Rare Dis; 2014 Dec; 9():210. PubMed ID: 25519771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study].
    Marcellusi A; Viti R; Incorvaia C; Mennini FS
    Recenti Prog Med; 2015 Oct; 106(10):517-27. PubMed ID: 26442978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review.
    Franklin M; Pollard D; Sah J; Rayner A; Sun Y; Dube F; Sutton A; Qin L
    Adv Ther; 2024 Jul; 41(7):2700-2722. PubMed ID: 38833143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.